{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:02:53Z","timestamp":1741924973635,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajg.2024.11.004","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:24:04Z","timestamp":1738009444000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of sofosbuvir and daclatasvir treatment on the blood indices in patients with chronic hepatitis C virus"],"prefix":"10.1016","volume":"26","author":[{"given":"Rabab","family":"Fouad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"El-Akel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"ElMakhzangy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania M","family":"Lithy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Fateen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Hassany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Abdel-Razek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahid","family":"Doss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.ajg.2024.11.004_b0005","first-page":"S179","article-title":"Benign and malignant hematological manifestations of chronic hepatitis C virus infection","volume":"5","author":"Kedia","year":"2014","journal-title":"Int J Prev Med"},{"issue":"1","key":"10.1016\/j.ajg.2024.11.004_b0010","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2017.019","article-title":"Thrombocytopenia in patients with chronic hepatitis c virus infection","volume":"9","author":"Dahal","year":"2017","journal-title":"Mediterr J hematol Infect diseases"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.004_b0015","doi-asserted-by":"crossref","DOI":"10.17795\/iji-35094","article-title":"Thrombocytopenia as a Clinical Manifestation of Hepatitis C Among Patients With a Positive Anti-HCV Test","volume":"3","author":"Bano","year":"2016","journal-title":"Int J Infect"},{"issue":"7","key":"10.1016\/j.ajg.2024.11.004_b0020","first-page":"20","article-title":"Anemia in Egyptian chronic Hepatitis C patients: Study of the causes prior to and during Interferon\/Ribavirin versus Sofosbuvir therapy","volume":"3","author":"Zaki","year":"2017","journal-title":"WJPMR"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.004_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000342964","article-title":"Severe neutropenia in patients with chronic hepatitis C: a benign condition","volume":"129","author":"Sheehan","year":"2013","journal-title":"Acta Haematol"},{"issue":"4","key":"10.1016\/j.ajg.2024.11.004_b0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jvh.12668","article-title":"National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care","volume":"24","author":"El-Akel","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ajg.2024.11.004_b0035","unstructured":"European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol 2018;69:461\u2013511."},{"key":"10.1016\/j.ajg.2024.11.004_b0040","unstructured":"Dean L. Blood Groups and Red Cell Antigens [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2005. Table 1, Complete blood count.Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2263\/table\/ch1.T1\/."},{"issue":"2","key":"10.1016\/j.ajg.2024.11.004_b0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.gastro.2018.10.033","article-title":"What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?","volume":"156","author":"Ioannou","year":"2019","journal-title":"Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.004_b0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.21608\/aeji.2019.15092.1031","article-title":"Efficacy of Sofosbuvir plus Daclatasvir in Treatment of Chronic HCV Infection in Egyptian Patients: A Prospective Cohort Study","volume":"9","author":"Badawy","year":"2019","journal-title":"Afro-Egyptian J Infect Endemic Diseases"},{"key":"10.1016\/j.ajg.2024.11.004_b0055","first-page":"168","article-title":"Clinical Characteristics of HCV in Egyptian Patients","volume":"6","author":"Naga","year":"2019","journal-title":"EC Gastroenterol Digest Syst"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.004_b0060","first-page":"173","article-title":"Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus","volume":"85","author":"Shawky","year":"2020","journal-title":"Revista de Gastroenterolog\u00eda de M\u00e9xico (EnglishEdition)"},{"issue":"7\u20138","key":"10.1016\/j.ajg.2024.11.004_b0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00335-016-9629-8","article-title":"Platelet function and ageing","volume":"27","author":"Jones","year":"2016","journal-title":"Mamm Genome"},{"issue":"6","key":"10.1016\/j.ajg.2024.11.004_b0070","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/etm.2010.150","article-title":"Age-related changes in peripheral blood counts in humans","volume":"1","author":"Mahlknecht","year":"2010","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1016\/j.ajg.2024.11.004_b0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5455\/jrmds.20142413","article-title":"Effect of aging on WBC count and Platelet count","volume":"2","author":"Padalia","year":"2017","journal-title":"J Res Medic Dental Sci"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.004_b0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.numecd.2018.12.007","article-title":"Platelet number is positively and independently associated with glycated hemoglobin in non-diabetic overweight and obese subjects","volume":"29","author":"De Pergola","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.ajg.2024.11.004_b0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/aid2.13102","article-title":"Determination of the predictive factors for significant liver fibrosis assessed through transient elastography","volume":"6","author":"Kao","year":"2019","journal-title":"Adv Digest Med"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.004_b0090","first-page":"155","article-title":"Current Management of Thrombocytopenia in Chronic Liver Disease","volume":"15","author":"Brown","year":"2019","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2024.11.004_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227544","article-title":"Platelet indices significantly correlate with liver fibrosis in HCV-infected patients","volume":"15","author":"Shao","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ajg.2024.11.004_b0100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/1535370217693113","article-title":"Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly","volume":"242","author":"Lv","year":"2017","journal-title":"Experiment Biol Med"},{"issue":"5","key":"10.1016\/j.ajg.2024.11.004_b0105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5604\/01.3001.0010.2717","article-title":"Treatment of chronic HCV infection with the new direct acting antivirals (DAA): First report of a real world experience in Southern Brazil","volume":"16","author":"Sette-Jr","year":"2017","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.ajg.2024.11.004_b0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/apt.13923","article-title":"Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt","volume":"45","author":"Elsharkawy","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ajg.2024.11.004_b0115","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/jgh.13758","article-title":"P P Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon","volume":"32","author":"Elsharkawy","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.ajg.2024.11.004_b0120","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020156","article-title":"Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.004_b0125","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/ijmm.IJMM_18_90","article-title":"The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors","volume":"36","author":"Zamani","year":"2018","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"10.1016\/j.ajg.2024.11.004_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151238","article-title":"Hemoglobin decrease with iron deficiency induced by daclatasvir plus asunaprevir combination therapy for chronic hepatitis C Virus genotype 1b","volume":"11","author":"Matsumoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ajg.2024.11.004_b0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijid.2018.07.025","article-title":"High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C","volume":"75","author":"Abozeid","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"28","key":"10.1016\/j.ajg.2024.11.004_b0140","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016242","article-title":"HCV compliance and treatment success rates are higher with DAAs in structured HCV clinics compared to general hepatology clinics","volume":"98","author":"Chehl","year":"2019","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.ajg.2024.11.004_b0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/03630242.2018.1449778","article-title":"A longitudinal study assessing depression in hepatitis C: Does gender play a role in the new-onset depression during interferon-alpha treatment?","volume":"59","author":"Fialho","year":"2019","journal-title":"Women Health"},{"issue":"12","key":"10.1016\/j.ajg.2024.11.004_b0150","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/14656566.2017.1346609","article-title":"Treatment of hepatitis C with new fixed dose combinations","volume":"18","author":"Soriano","year":"2017","journal-title":"Expert Opin Pharmacother"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719792400128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719792400128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T03:38:27Z","timestamp":1741837107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168719792400128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S168719792400128X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2024.11.004","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sofosbuvir and daclatasvir treatment on the blood indices in patients with chronic hepatitis C virus","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2024.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}